Table 3.
Group | CD4+ T cells /μl | Viral Load(Log10 copies /ml) |
---|---|---|
Before commencement of HAART {a} (n = 50) | 152 ± 67 | 5.45 ± 0.37 |
6 Months into HAART {b} (n = 50) | 378 ± 162 | 2 .70 ± 0.63 |
1 Year into HAART{c} (n = 50) | 522 ± 160 | 0.18 ± 0.04 |
Control {d} (n = 50) | 900 ± 245 | – |
F Value | 67.73 | 33.09 |
P Value | 0.00 | 0.00 |
{a} Vs {b} | P < 0.05 | P < 0.05 |
{a} Vs {c} | P < 0.05 | P < 0.05 |
{a} Vs {d} | P < 0.05 | – |
{b} Vs {c} | P < 0.05 | P < 0.05 |
{b} Vs {d} | P < 0.05 | – |
{c} Vs {d} | P < 0.05 | – |
Vs Versus, HAART Highly Active Antiretroviral Therapy, n number of participants